2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

被引:21
作者
Yeon, Jong Eun [1 ]
Kim, In Hee [2 ]
Lee, Jung Il [3 ]
Kim, Kyung-Ah [4 ]
Gwak, Geum-Youn [5 ]
Kim, Ji Hoon [1 ]
Kim, Kang Mo [6 ]
Jang, Jeong Won [7 ]
Kim, Do Young [3 ]
Yoon, Ki Tae [8 ]
机构
[1] Korea Univ, Coll Med, Seoul, South Korea
[2] Chonbuk Natl Univ, Med Sch, Jeonju, South Korea
[3] Yonsei Univ, Coll Med, Seoul, South Korea
[4] Inje Univ, Coll Med, Gimhae, South Korea
[5] Sungkyunkwan Univ, Sch Med, Seoul, South Korea
[6] Univ Ulsan, Coll Med, Ulsan, South Korea
[7] Catholic Univ Korea, Coll Med, Seoul, South Korea
[8] Pusan Natl Univ, Sch Med, Busan, South Korea
关键词
Chronic hepatitis C; Treatment; Direct acting antivirals; Guidelines; VIRUS GENOTYPE 1; SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-EXPERIENCED PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; HUMAN-IMMUNODEFICIENCY-VIRUS; ACTING ANTIVIRAL THERAPY; ADVANCED LIVER-DISEASE; RESISTANCE-ASSOCIATED SUBSTITUTIONS; PREVIOUSLY UNTREATED PATIENTS; HIV/HCV-COINFECTED PATIENTS;
D O I
10.3350/cmh.2018.1004
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:169 / 229
页数:61
相关论文
共 240 条
[1]   Ledipasvir Plus Sofosbuvir for 12 Weeks in Patients With Hepatitis C Genotype 4 Infection [J].
Abergel, Armand ;
Metivier, Sophie ;
Samuel, Didier ;
Jiang, Deyuan ;
Kersey, Kathryn ;
Pang, Phillip S. ;
Svarovskaia, Evguenia ;
Knox, Steven J. ;
Loustaud-Ratti, Veronique ;
Asselah, Tarik .
HEPATOLOGY, 2016, 64 (04) :1049-1056
[2]   Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study [J].
Abergel, Armand ;
Asselah, Tarik ;
Metivier, Sophie ;
Kersey, Kathryn ;
Jiang, Deyuan ;
Mo, Hongmei ;
Pang, Phillip S. ;
Samuel, Didier ;
Loustaud-Ratti, Veronique .
LANCET INFECTIOUS DISEASES, 2016, 16 (04) :459-464
[3]   Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Zeuzem, Stefan ;
Kwo, Paul ;
Chojkier, Mario ;
Gitlin, Norman ;
Puoti, Massimo ;
Romero-Gomez, Manuel ;
Zarski, Jean-Pierre ;
Agarwal, Kosh ;
Buggisch, Peter ;
Foster, Graham R. ;
Braeu, Norbert ;
Buti, Maria ;
Jacobson, Ira M. ;
Subramanian, G. Mani ;
Ding, Xiao ;
Mo, Hongmei ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Mangia, Alessandra ;
Marcellin, Patrick .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (20) :1889-1898
[4]   Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Reddy, K. Rajender ;
Nelson, David R. ;
Lawitz, Eric ;
Gordon, Stuart C. ;
Schiff, Eugene ;
Nahass, Ronald ;
Ghalib, Reem ;
Gitlin, Norman ;
Herring, Robert ;
Lalezari, Jacob ;
Younes, Ziad H. ;
Pockros, Paul J. ;
Di Bisceglie, Adrian M. ;
Arora, Sanjeev ;
Subramanian, G. Mani ;
Zhu, Yanni ;
Dvory-Sobol, Hadas ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
Kwo, Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) :1483-1493
[5]   SOF/VEL FOR 12 WEEKS RESULTS IN HIGH SVR12 RATES IN SUBJECTS WITH NEGATIVE PREDICTORS OF RESPONSE TO TREATMENT: AN INTEGRATED ANALYSIS OF EFFICACY FROM THE ASTRAL-1, ASTRAL-2 AND ASTRAL-3 STUDIES [J].
Agarwal, K. ;
Patel, K. ;
Samuel, D. ;
Bourliere, M. ;
Younes, Z. ;
Morgan, T. ;
Strasser, S. ;
Leggett, B. ;
Liu, L. ;
Ding, X. ;
McNally, J. ;
Osinusi, A. ;
Brainard, D. ;
Subramanian, M. ;
Afdhal, N. .
JOURNAL OF HEPATOLOGY, 2016, 64 :S787-S788
[6]   A phase 3b study of sofosbuvir plus ribavirin in treatment-naive and treatment-experienced Korean patients chronically infected with genotype 2 hepatitis C virus [J].
Ahn, S. H. ;
Lim, Y. S. ;
Lee, K. S. ;
Paik, S. W. ;
Lee, Y. J. ;
Jeong, S. H. ;
Kim, J. H. ;
Yoon, S. K. ;
Yim, H. J. ;
Tak, W. Y. ;
Han, S. Y. ;
Yang, J. C. ;
Mo, H. ;
Mathias, A. ;
Han, L. ;
Knox, S. J. ;
Brainard, D. M. ;
Kim, Y. J. ;
Byun, K. S. ;
Kim, Y. S. ;
Heo, J. ;
Han, K. H. .
JOURNAL OF VIRAL HEPATITIS, 2016, 23 (05) :358-365
[7]   Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens [J].
Akuta, Norio ;
Sezaki, Hitomi ;
Suzuki, Fumitaka ;
Fujiyama, Shunichiro ;
Kawamura, Yusuke ;
Hosaka, Tetsuya ;
Kobayashi, Masahiro ;
Kobayashi, Mariko ;
Saitoh, Satoshi ;
Suzuki, Yoshiyuki ;
Arase, Yasuji ;
Ikeda, Kenji ;
Kumada, Hiromitsu .
JOURNAL OF MEDICAL VIROLOGY, 2017, 89 (07) :1248-1254
[8]   Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort [J].
Alonso, S. ;
Riveiro-Barciela, M. ;
Fernandez, I. ;
Rincon, D. ;
Real, Y. ;
Llerena, S. ;
Gea, F. ;
Olveira, A. ;
Fernandez-Carrillo, C. ;
Polo, B. ;
Carrion, J. A. ;
Gomez, A. ;
Devesa, M. J. ;
Baliellas, C. ;
Castro, A. ;
Ampuero, J. ;
Granados, R. ;
Pascasio, J. M. ;
Rubin, A. ;
Salmeron, J. ;
Badia, E. ;
Planas, J. M. M. ;
Lens, S. ;
Turnes, J. ;
Montero, J. L. ;
Buti, M. ;
Esteban, R. ;
Fernandez-Rodriguez, C. M. .
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (04) :304-311
[9]   Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trials [J].
Alqahtani, Saleh A. ;
Afdhal, Nezam ;
Zeuzem, Stefan ;
Gordon, Stuart C. ;
Mangia, Alessandra ;
Kwo, Paul ;
Fried, Michael ;
Yang, Jenny C. ;
Ding, Xiao ;
Pang, Phillip S. ;
McHutchison, John G. ;
Pound, David ;
Reddy, K. Rajender ;
Marcellin, Patrick ;
Kowdley, Kris V. ;
Sulkowski, Mark .
HEPATOLOGY, 2015, 62 (01) :25-30
[10]   Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons [J].
Alvarez, D. ;
Dieterich, D. T. ;
Brau, N. ;
Moorehead, L. ;
Ball, L. ;
Sulkowski, M. S. .
JOURNAL OF VIRAL HEPATITIS, 2006, 13 (10) :683-689